Comments
Loading...

Theravance Biopharma

TBPHNASDAQ
Logo brought to you by Benzinga Data
$8.29
0.020.24%
Last update: 11:07 AM
15 minutes delayed

Theravance Biopharma (NASDAQ:TBPH) Stock, Earnings Estimates, EPS, And Revenue

Theravance Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 5
EPS Estimate
$-0.230
Quarterly Revenue Estimate
$15.3M
Annual Revenue
(as of Jun 30)
$62M

Analyze the earnings history of Theravance Biopharma using advanced sorting and filters.

Data brought to you by Benzinga APIs

Theravance Biopharma (TBPH) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Jun 20242024-08-05$-0.13$-0.2138.1 %
Mar 20242024-05-13$-0.09$-0.2564.0 %
Dec 20232024-02-26$-0.17$-0.15-13.3 %
Sep 20232023-11-07$-0.17$-0.2119.1 %

Theravance Biopharma (TBPH) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Jun 20242024-08-05$14.26M$15.45M-7.73 %
Mar 20242024-05-13$14.50M$13.96M3.89 %
Dec 20232024-02-26$17.57M$17.68M-0.65 %
Sep 20232023-11-07$15.69M$15.00M4.62 %

FAQ

Q

When is Theravance Biopharma (NASDAQ:TBPH) reporting earnings?

A

Theravance Biopharma (TBPH) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 5, 2024 for Q2.

Q

What were the latest earnings per share (EPS) for Theravance Biopharma (NASDAQ:TBPH)?

A

The Actual EPS was $-0.13, which beat the estimate of $-0.21.

Q

What were Theravance Biopharma’s (NASDAQ:TBPH) revenues?

A

The Actual Revenue was $14.3M, which missed the estimate of $15.4M.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch